LATEST PRESS RELEASES

Silo Pharma Announces Participation on Webull Corporate Communications Service Platform

Silo Pharma, Inc.Webull’s investor community can now access the SILO profile for real-time data and investor communicationsENGLEWOOD CLIFFS, NJ, June 02, 2023 -- Silo Pharma, Inc.Β (Nasdaq: SILO) (β€œthe Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today ann... Read More...

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023

VANCOUVER, BC, June 2, 2023 - Numinus Wellness Inc.Β ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO, will participate in a Water Tower Research Fireside Chat on Wednesday, June... Read More...

Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors

VANCOUVER, British Columbia, May 29, 2023 -- Mydecine Innovations Group Inc. (β€œMydecine” or the β€œCompany”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, is pleased to a... Read More...

Red Light Holland Reminder to Shareholders as the Company Celebrates its Third Listing Anniversary on The CSE by Conducting a Live Q&A Today at 1pm ET

Toronto, Ontario--(Newsfile Corp. - May 26, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the le... Read More...

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

First Numinus Networkβ„’ partner enters into agreement Recent cost containment initiatives have resulted in approximately $4.2 million of annualized savings, extending cash runway Well positioned to provide psychedelic-assisted therapy insurance reimbursement, as a result of recent US insurance payor code approval MDMA-assisted therapy e... Read More...

Red Light Holland Celebrates its Third Listing Anniversary on the CSE by Conducting a Live Q&A on May 26, 2023 at 1pm ET Hosted by CEO Todd Shapiro

Toronto, Ontario--(Newsfile Corp. - May 19, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the le... Read More...

Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemiaβ„’

Distribution Agreement Grants Pentec Exclusive Distribution Rights for Altemia Lobe’s Novel Sickle Cell Anemia Medical FoodVANCOUVER, British Columbia, May 17, 2023--(BUSINESS WIRE)--Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"), a biopharmaceutical company focused on developing transformative medicines to treat orphan diseases t... Read More...

Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease

<!-- Name:DistributionId Value:8834701 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:3763 --> <!-- Name:CustomerId Value:500069339 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:a9b7e2ab-bdd4-4b40-bbb8-91ab572edbcc --> ENGLEWOOD CL... Read More...

Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development

Optimi Health Corp.The Company’s entire cultivation facility has been mobilized to service supply agreementsVANCOUVER, British Columbia, May 04, 2023 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (β€œOptimi” or the β€œCompany”), today announced that it has entered into a CAD$1.2 million definitive supply agreement with a privat... Read More...

COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023

COMPASS PathwaysLONDON, May 03, 2023 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter 2023, and provide an update on recent business developments on 11 May... Read More...

Revive Therapeutics Announces Data Safety Monitoring Board Meeting Date on Phase 3 Clinical Study of Bucillamine in the Treatment of COVID-19

<!-- Name:DistributionId Value:8829672 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value:4573 --> <!-- Name:CustomerId Value:1105448 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:7bb166ba-7a1b-4f4b-9e81-06921a47977b --> TORONTO, May 02... Read More...

Red Light Holland Publishes Report on Psilocybin Microdosing In Collaboration With NUBU Pharmaceuticals Aimed At NUBU’s Pharmaceutical’s Network Of Medical Doctors In Australasia

Toronto, Ontario--(Newsfile Corp. - April 26, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to t... Read More...

Red Light Holland Engages World Famous Media Personality Mia Khalifa as Advisor to help with Social Media Guidance and Exposure and to Develop a Female-Focused Mushroom Brand

Toronto, Ontario--(Newsfile Corp. - April 25, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocy... Read More...

Lobe Sciences, Ltd. Provides Update on Vitamind

Vancouver, British Columbia--(Newsfile Corp. - April 21, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical Company committed to discovering and developing patient-focused medicines for Orphan and Rare diseases today provides an update on its acquisition of the Vitamind Bran... Read More...

Red Light Holland Receives Certificate of Analysis for Their Dehydrated Homogenized Natural Psilocybin Developed and Tested by Partner CCrest Laboratories Aimed for Distribution with NUBU Pharmaceuticals in Australasia

Certificate of Analysis issued for processed psilocybin truffles imported from Red Light Holland's farm in the Netherlands by CCrest Laboratories.Child proof packaging has been sourced.Toronto, Ontario--(Newsfile Corp. - April 21, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland"), a company engage... Read More...

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Bright Minds Biosciences-- BMB-202 is a highly selective 5-HT2A agonist that exhibits a more than 30-fold selectivity over 5-HT2C and more than 500-fold selectivity over 5-HT2BΒ ---- BMB-202 is the first clinical candidate from an extensive portfolio of selective 5-HT2A and 5-HT2A/2C agonists inspired from natural compound scaffolds --VANC... Read More...

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, April 19, 2023

VANCOUVER, BC, April 17, 2023 - Numinus Wellness Inc.Β ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO, will participate in a Water Tower Research Fireside Chat on Wednesday, Ap... Read More...

Cybin Announces EMBARK Open Access, the First Free Online Course Providing Facilitator Training for Psychedelic Therapy

TORONTO, April 12, 2023--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced the launch of EMBARK Open Access ("EMBARK OA"), a f... Read More...

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

<!-- Name:DistributionId Value:8804303 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 --> <!-- Name:CustomerId Value:1215554 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:5a4f8d74-a5c7-45ff-825b-146eb8df4874 --> β€”Β Presentation... Read More...

Red Light Holland Announces AEM New Brunswick Shiitake Mushrooms Are Available in over 100 Locations Including All 47 Farm Boy Stores in Ontario, Canada

AEM New Brunswick Shiitake Mushrooms, via distribution partners, are available in 47 Farm Boy stores across OntarioWith the addition of the Farm Boy locations, AEM New Brunswick produced Shiitake Mushrooms are now available in over 100 retail stores in Eastern Canada, including Loblaws owned retailers in Ottawa; Costco locations in both O... Read More...

Delic Holdings Corp. Signs LOI with Peter/PetraMD to Acquire Ketamine Wellness Centers and Facilitate Online Ketamine Treatments Nationwide

VANCOUVER, British Columbia, April 03, 2023--(BUSINESS WIRE)--Peter/PetraMD, the largest online provider of hormone therapy for men and women in the United States, today announced the intent to acquire Ketamine Wellness Centers. If successful, the acquisition would represent an incredible on-ramp into the ketamine space for Peter/PetraMD.... Read More...

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Revive Therapeutics Ltd.First subject enrolled and initial top-line results expected in Q3-2023TORONTO, March 28, 2023 -- Revive Therapeutics Ltd. (β€œRevive” or the β€œCompany”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disor... Read More...

Numinus Launches the Practitioner Certification Pathway

VANCOUVER, BC, March 27, 2023 -Β Numinus Wellness Inc.Β ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has launched the Numinus Certification Pathway – a collection of psychedelic-assisted therapy ("PAT") tr... Read More...

Red Light Holland and Mera Life Sciences Terminate Agreement in St. Vincent and the Grenadines

Toronto, Ontario--(Newsfile Corp. - March 23, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the l... Read More...